Adjuvant Immunotherapy after Curative Treatment for Hepatocellular Carcinoma

被引：24
|
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan
来源：
LIVER CANCER | 2021年 / 10卷 / 05期
关键词：
Hepatocellular carcinoma; Nivolumab; Adjuvant immunotherapy; Anti-VEGF antibody; ATEZOLIZUMAB PLUS BEVACIZUMAB; DOUBLE-BLIND; RECURRENCE; RESECTION; ABLATION;
D O I：
10.1159/000518584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：399 / 403
页数：5
相关论文
共 50 条
  • [41] Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
    Cammarota, Antonella
    Zanuso, Valentina
    Manfredi, Giulia Francesca
    Murphy, Ravindhi
    Pinato, David James
    Rimassa, Lorenza
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [42] Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma
    Chong, Charing Ching-Ning
    Cheung, Siu Tim
    Cheung, Yue-Sun
    Chan, Anthony Wing-Hung
    Chan, Stephen Lam
    Yu, Simon Chun-Ho
    Lai, Paul Bo-San
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (06) : 524 - 530
  • [43] Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
    Lee, Soon Kyu
    Lee, Sung Won
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [44] Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
    Dai, Mu-Gen
    Liu, Si-Yu
    Lu, Wen-Feng
    Liang, Lei
    Ye, Bin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [45] Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma
    Miyatake, Hirokazu
    Kobayashi, Yoshiyuki
    Iwasaki, Yoshiaki
    Nakamura, Shin-ichiro
    Ohnishi, Hideki
    Kuwaki, Kenji
    Toshimori, Junichi
    Hagihara, Hiroaki
    Nouso, Kazuhiro
    Yamamoto, Kazuhide
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 1092 - 1101
  • [46] African Americans are less likely to receive curative treatment for hepatocellular carcinoma
    Sobotka, Lindsay A.
    Hinton, Alice
    Conteh, Lanla F.
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (11) : 849 - 855
  • [47] African Americans are less likely to receive curative treatment for hepatocellular carcinoma
    Lindsay A Sobotka
    Alice Hinton
    Lanla F Conteh
    World Journal of Hepatology, 2018, (11) : 849 - 855
  • [48] Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma
    Ng, K. M.
    Niu, R.
    Yan, T. D.
    Zhao, J.
    McKay, E.
    Chu, F. C. K.
    Morris, D. L.
    HPB, 2008, 10 (06) : 388 - 395
  • [49] US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment
    Hui Huang
    Mei-Qing Cheng
    Dan-Ni He
    Meng-Fei Xian
    Dan Zeng
    Shao-Hong Wu
    Chao-Qun Li
    Si-Min Ruan
    Ming-De Li
    Man-Xia Lin
    Ming-De Lu
    Ming Kuang
    Wei Wang
    Li-Da Chen
    European Radiology, 2023, 33 : 9357 - 9367
  • [50] US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment
    Huang, Hui
    Cheng, Mei-Qing
    He, Dan-Ni
    Xian, Meng-Fei
    Zeng, Dan
    Wu, Shao-Hong
    Li, Chao-Qun
    Ruan, Si-Min
    Li, Ming-De
    Lin, Man-Xia
    Lu, Ming-De
    Kuang, Ming
    Wang, Wei
    Chen, Li-Da
    EUROPEAN RADIOLOGY, 2023, 33 (12) : 9357 - 9367
12345